BIONET Corp. (TPEX: 1784)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
103.00
0.00 (0.00%)
Sep 11, 2024, 10:10 AM CST
61.19%
Market Cap 4.87B
Revenue (ttm) 1.16B
Net Income (ttm) 62.74M
Shares Out 47.29M
EPS (ttm) 1.32
PE Ratio 77.92
Forward PE n/a
Dividend 0.71 (0.67%)
Ex-Dividend Date Sep 19, 2024
Volume 124,498
Open 103.50
Previous Close 103.00
Day's Range 102.50 - 104.50
52-Week Range 55.60 - 173.50
Beta 0.74
Analysts n/a
Price Target n/a
Earnings Date Nov 11, 2024

About BIONET

BIONET Corp. provides cord blood banking services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC + immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products. In addition, the company offers Exosome, a novel cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan. [Read more]

Sector Healthcare
Founded 1989
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1784
Full Company Profile

Financial Performance

In 2023, BIONET's revenue was 1.13 billion, an increase of 14.99% compared to the previous year's 980.38 million. Earnings were 78.40 million, an increase of 106.47%.

Financial Statements

News

There is no news available yet.